UNIVERSITY OF CINCINNATI
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1819-01-01
- Employees
- 5.9K
- Market Cap
- -
- Website
- https://www.uc.edu/
Enhancing Operability in a Hypobaric Hypoxic Environment With a Small Oxygen Storage System
Not yet recruiting
- Conditions
- First Posted Date
- 2017-12-07
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 20
- Registration Number
- NCT03365128
EMPOWER: Randomized Trial of Online Chronic Pain Management Program to Reduce Reliance on Opioid Analgesic Medications
- First Posted Date
- 2017-10-12
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 402
- Registration Number
- NCT03308188
- Locations
- ๐บ๐ธ
Duke Health, Durham, North Carolina, United States
๐บ๐ธUC Health, Cincinnati, Ohio, United States
Budesonide for Liver Transplant Immune Suppression
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-10-09
- Last Posted Date
- 2021-07-20
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 40
- Registration Number
- NCT03304626
- Locations
- ๐บ๐ธ
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Exhaled Carbon Monoxide and Red Blood Cell Turnover
- Conditions
- Interventions
- First Posted Date
- 2017-09-20
- Last Posted Date
- 2017-09-20
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 30
- Registration Number
- NCT03288233
- Locations
- ๐บ๐ธ
University of Cincinnati, Cincinnati, Ohio, United States
Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma
- First Posted Date
- 2017-09-11
- Last Posted Date
- 2021-11-24
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 11
- Registration Number
- NCT03278249
- Locations
- ๐บ๐ธ
UC Health, Cincinnati, Ohio, United States
Inhaled Nitric Oxide in Brain Injury
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-08-24
- Last Posted Date
- 2024-01-02
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 13
- Registration Number
- NCT03260569
- Locations
- ๐บ๐ธ
University of Cincinnati, Cincinnati, Ohio, United States
Pirfenidone for Progressive Fibrotic Sarcoidosis
- First Posted Date
- 2017-08-24
- Last Posted Date
- 2017-09-28
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 60
- Registration Number
- NCT03260556
- Locations
- ๐บ๐ธ
University of Cincinnati, Cincinnati, Ohio, United States
Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2017-08-22
- Last Posted Date
- 2021-09-28
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 70
- Registration Number
- NCT03257670
- Locations
- ๐บ๐ธ
University of Cincinnati, Cincinnati, Ohio, United States
Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial
- First Posted Date
- 2017-08-18
- Last Posted Date
- 2023-02-01
- Lead Sponsor
- University of Cincinnati
- Target Recruit Count
- 25
- Registration Number
- NCT03253913
- Locations
- ๐บ๐ธ
University of Cincinnati, Cincinnati, Ohio, United States
The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG
- First Posted Date
- 2017-07-24
- Last Posted Date
- 2018-03-20
- Lead Sponsor
- University of Cincinnati
- Registration Number
- NCT03227393
- Locations
- ๐บ๐ธ
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath